8–9 November 2018 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress
Oxford Global would like to present to you the 10th Annual Next Generation Sequencing & Clinical Diagnostics Congress to be held on the 8-9 November 2018 in London. It is an outstanding and comprehensive programme discussing the critical developments in shaping next generation sequencing, drug development and personalised healthcare. Celebrating its tenth year anniversary, the congress is part of the Genomics and Synthetic Biology Series. It attracts over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
Benefits of attending
- Learn more about NGS in Pharma: biomarker development, precision medicine and clinical diagnostics. Case studies include: NGS in drug discovery and development, biomarkers for precision therapies and clinical genomics in immunotherapy, oncology, infectious and hereditary diseases as well as pre-natal genetic testing
- NGS and genomics in Healthcare: discuss the use of latest NGS and Genomic technologies in patient care, diagnosis and therapeutic development, clinical diagnostics development, informatics and Genomic profiling
- Discover collaborative solutions to next generations sequencing. This prestigious congress brings together key opinion leaders to discuss topic areas ranging from novel methods to NGS data analysis and whole genome sequencing